Peter T. Masiakos

Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness

Paul P. Szotek, Rafael Pieretti‐Vanmarcke, Peter T. Masiakos et al. · Proceedings of the National Academy of Sciences · 2006 · 756 citations · Full text

Oncogenic Agent, Medicine, Stem Cells +14

A biodegradable and biocompatible gecko-inspired tissue adhesive

Alborz Mahdavi, Lino Ferreira, Cathryn A. Sundback et al. · Proceedings of the National Academy of Sciences · 2008 · 546 citations · Full text

Tissue Engineering, Porcine Intestine Tissue, Engineering +11

Human ovarian cancer, cell lines, and primary ascites cells express the human Mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MIS.

Peter T. Masiakos, David T. MacLaughlin, Shyamala Maheswaran et al. · PubMed · 1999 · 122 citations

Flow Cytometry, Type Ii Receptor, Oncogenic Agent +13

A Highly Tunable Biocompatible and Multifunctional Biodegradable Elastomer

Maria Pereira, Ben Ouyang, Cathryn A. Sundback et al. · Advanced Materials · 2012 · 112 citations · Full text

Materials Science, Tissue Engineering, Biodegradable Elastomers +14

Clinical Clearance of the Cervical Spine in Blunt Trauma Patients Younger Than 3 Years: A Multi-Center Study of the American Association for the Surgery of Trauma

Rafael Pieretti‐Vanmarcke, George C. Velmahos, Michael L. Nance et al. · The Journal of Trauma: Injury, Infection, and Critical Care · 2009 · 111 citations